{"id":"42e00a63-9d67-480a-9e3b-6c4e16eed4b6","arxiv_id":"2507.05329","paper_version":1,"verdict":"REJECT","confidence":"MODERATE","novelty_score":4.0,"correctness_risk":"high","formal_verification":"none","parameter_count":3,"one_line_summary":"Brillouin shift and linewidth medians differ slightly between wild-type and CRISPR-modified colon cancer cells, but no statistical significance is established.","lead":"Researchers used a laser-based microscope called Brillouin microscopy to compare colon cancer cells that were either unmodified or edited with CRISPR. They report small differences in the cells' mechanical readings, but the paper lacks statistical tests to confirm the differences.","discovery_kind":"extension","skeptic_critique":{"model":"deepseek-v4-flash","headline":"Abstract claims 'statistical analysis revealed' differences, but Results states 'further statistical analysis is underway'; no test, CI, or effect size supports the 0.024 GHz shift difference, so the central claim is not established.","rationale":"Good-faith reading: the paper's strength is the detailed custom Brillouin spectrometer description—confocal pinhole alignment, VIPA dispersion calibration, iodine-cell suppression—and the authors' stated effort to withhold stiffness values to reduce confirmation bias. The measured median values are clearly reported. However, the central argument fails at the inference step. The only evidence for differentiation is a pair of medians without any uncertainty quantification. The delta shift is 0.024 GHz; no calibration or repeatability value is reported, so we do not know whether 24 MHz is above instrument resolution or noise. The abstract and results contradict each other on whether statistics were completed. The CRISPR model is not characterized, so even a robust optical difference would not clearly be attributable to the edit. Given that the manuscript itself flags statistics as 'underway,' the REJECT verdict is appropriate. My read does not alter the reader's verdict.","tokens_in":9962,"tokens_out":4230,"duration_ms":54547,"concrete_test":"Request the per-cell median Brillouin shift and FWHM for all measured cells (or the raw spectra) and rerun the comparison with cells as the unit of analysis: compute a bootstrap 95% confidence interval for the WT−CRISPR difference and a Mann-Whitney U test. If the CI includes 0 or p>0.05, the claimed differentiation is not established. As a companion check, estimate measurement repeatability from repeated acquisitions of the same or a reference sample; if repeatability exceeds the 0.024 GHz shift difference, the headline result is indistinguishable from instrument noise.","verdict_should_be":"UNCHANGED","load_bearing_attack":"The central claim requires that the 24 MHz median Brillouin shift difference (7.591 vs 7.567 GHz) and the 126 MHz FWHM difference (0.987 vs 0.861 GHz) are real, reproducible, and attributable to the CRISPR edit. None of these conditions is currently supported. The Abstract asserts 'statistical analysis revealed' significant differences, but Section 3 states 'Further statistical analysis is underway to ascertain the significance of these differences'—a direct internal contradiction. No confidence interval, p-value, effect size, or measure of pixel/cell variability is reported, and no replicate flasks or independent cultures are described. The comparison groups are also not validated: Section 2 identifies samples only by handwritten labels ('RKo P7...' vs 'RKo mutant DMEM...'), with no gene target, genotyping, or characterization of the edit, and Section 3 says twenty cells were 'arbitrarily selected.' Even if the medians differ, passage number, culture medium, or selection bias are equally plausible explanations. Because the paper's own text concedes that significance testing is incomplete, the conclusion that Brillouin spectroscopy 'effectively resolves' differences is an overclaim rather than an established result.","agreement_with_reader":"agree"},"referee_report":{"model":"deepseek-v4-flash","summary":"The manuscript reports a proof-of-concept application of custom-built confocal Brillouin microspectroscopy to compare wild-type (WT) and CRISPR-modified colon cancer cells. The authors measured Brillouin shift and full width at half maximum (FWHM) from selected cells and report median values of 7.591 GHz versus 7.567 GHz for the shift and 0.987 GHz versus 0.861 GHz for the FWHM, concluding that Brillouin spectroscopy can effectively resolve subtle viscoelastic differences between the two groups. The paper includes a detailed description of the optical setup, spectral pre-processing, and representative heatmaps and box plots, but it provides no inferential statistics, no validation of the CRISPR modification, and only descriptive comparisons of the two sample groups.","tokens_in":10174,"tokens_out":3808,"duration_ms":46227,"significance":"If the reported differences were established, the result would be a useful proof-of-concept for label-free, non-invasive mechanical phenotyping of genetically modified cells, with potential relevance to cancer research and diagnostics. The instrumentation description is a genuine strength: the authors specify calibration through the VIPA free spectral range and the iodine absorption line, report >40 dB elastic suppression, and describe confocal pinhole validation. They also took a sensible step to mitigate confirmation bias by withholding expected stiffness values. However, the central claim currently rests entirely on descriptive medians without statistical support, and the biological identity of the comparison groups is not verified. The paper's own text concedes that significance testing is incomplete, so the conclusion as written is not supported by the data presented.","major_comments":[{"comment":"The Abstract states that \"Statistical analysis revealed that WT cells had different stiffness and viscosity compared to CRISPR-modified cells,\" but Section 3 explicitly states: \"Further statistical analysis is underway to ascertain the significance of these differences.\" No p-values, confidence intervals, effect sizes, or measures of variability relative to the 0.024 GHz shift difference are reported. Since the central claim depends on demonstrating that the observed median differences are not measurement noise, the manuscript's own text concedes that the claim is not yet established.","section":"Abstract / Section 3"},{"comment":"The two comparison groups are not validated as wild-type versus CRISPR-modified. Section 2 identifies the samples only by handwritten flask labels (\"RKo P7 9/10/24 AC P8 9/12/24\" and \"RKo mutant DMEM P7 9/13/24 KM\"), with no description of the edited gene, no genotyping, and no characterization of the intended modification. The labels also reveal different passage dates and a medium label (\"DMEM\"), so passage number and culture medium are visible confounders. The attribution of the Brillouin differences to the CRISPR edit is therefore unsupported.","section":"Section 2 / Section 3"},{"comment":"The quantitative analysis is based on \"twenty representative cells [that] were arbitrarily selected\" from each group. No sampling protocol, no replicate cultures, and no account of inter-cell or inter-pixel variability are given beyond the box plots. Without replicates or a defined selection criterion, the median differences could reflect selection bias, batch effects, or other uncontrolled experimental factors rather than a genuine biological difference.","section":"Section 3"},{"comment":"Section 2.1, titled \"Sample preparation,\" is empty. No information is provided about the cell line, culture conditions, CRISPR protocol, or sample handling. This omission prevents reproducibility and makes it impossible to assess the confounders noted above.","section":"Section 2.1"}],"minor_comments":[{"comment":"Several citations are malformed: \"tumorigenesis3\" and \"as a potential therapeutic target6\" appear without brackets, and some reference entries are incomplete (e.g., reference [42] lacks a title).","section":"Section 1"},{"comment":"The box plots would benefit from annotations specifying the number of cells/pixels, the whisker definition, and any outliers; currently the reader cannot determine the spread or robustness of the medians.","section":"Figure 4"},{"comment":"The statement that \"the observed light pattern closely resembled the Fraunhofer diffraction pattern on the power meter\" is unclear, since a power meter measures integrated power rather than spatial pattern; this should be reworded or supported by an image.","section":"Section 2.2.3"},{"comment":"The Savitzky-Golay filter parameters (window width 7, polynomial order 3) are stated but no sensitivity analysis or justification is provided for their optimality.","section":"Section 2.3"}],"recommendation":"reject","confidential_remarks":"The central claim is not supported by the manuscript's own evidence, and the internal contradiction between the Abstract and Section 3 is difficult to resolve by simple editing because the missing statistical analysis is acknowledged as ongoing. More importantly, the samples are not validated as WT versus CRISPR-modified, and the flask labels introduce passage and medium confounders that cannot be corrected retrospectively within the scope of a revision; new experiments with validated, matched samples would be needed. I therefore recommend rejection, though the instrumentation description itself could form the basis of a future manuscript if the experimental validation is completed."},"author_rebuttal":null,"desk_editor":{"model":"deepseek-v4-flash","letter":"First, the thing to know: this is a technically solid Brillouin microscopy paper with a central biological claim that the data as presented do not support. The abstract says \"statistical analysis revealed\" differences, but the Results section says \"further statistical analysis is underway\" — a direct internal contradiction. The reported 24 MHz shift difference and 126 MHz FWHM difference are just medians, with no p-values, confidence intervals, or effect sizes.\n\nWhat is genuinely good: the instrumentation description is careful and reproducible. The authors calibrated the VIPA dispersion, used an iodine cell for stray-light suppression, checked pinhole size against one Airy unit, and specified the signal-processing steps. A reader building a Brillouin setup would find this a useful methods reference. The WT versus CRISPR-edited RKO comparison is a new measurement, a legitimate incremental application of an established technique.\n\nThe problems are load-bearing. The CRISPR line is undefined: no gene target, no genotyping, no validation of the edit. Samples are identified only by handwritten labels, and the two conditions differ in passage number and possibly medium. Twenty cells per group were arbitrarily selected from one flask each, with no replicates. The authors even acknowledge in the conclusion that heterogeneity, stress effects, and nuclear contribution could affect the parameters. So the observed median differences could easily reflect passage, culture conditions, or selection bias rather than the edit. The conclusion that Brillouin spectroscopy \"effectively resolves\" the difference is an overclaim.\n\nMinor note: the introduction is padded with general colorectal cancer epidemiology that doesn't connect to the work, but that's not a scientific issue.\n\nWho this is for: anyone working on Brillouin instrumentation will get value from the methods section; anyone interested in label-free phenotyping of edited cells will find the question attractive but the answer not yet established. This reads like a preliminary pilot report rather than a finished study.\n\nRecommendation: I would send it to peer review rather than desk reject — the technical core is real, and the authors can address the main objection by adding proper statistics and biological validation. But I would not accept it in this form. The authors need to either supply the missing analysis or reframe the paper as a methods note without the \"demonstrates\" claim.","headline":"Solid Brillouin instrumentation with a central biological claim the data don't yet support; the abstract overstates what the results show.","tokens_in":10701,"tokens_out":2216,"would_cite":false,"duration_ms":27102,"reading_group":"maybe","serious_thinker":"yes","would_accept_peer_review":true},"rs_alignment":null,"lean_confirmation":null,"pith_extraction":{"msc":[],"pacs":[],"model":"deepseek-v4-flash","headline":"Brillouin microscopy can tell CRISPR-edited colon cancer cells from wild-type cells by their mechanical signatures.","keywords":["Brillouin microscopy","Brillouin shift","full width at half maximum","colon cancer","CRISPR","cell viscoelasticity","label-free imaging"],"falsifier":"A direct falsifier would be PCR or sequencing of the flask populations showing that the intended CRISPR modification is absent or present in only a minority of cells, or a blinded replication in which passage- and media-matched wild-type and edited clones produce overlapping medians for shift and FWHM. Another concrete check is to swap the sample identities between flasks and see whether the assignment follows the physical flask rather than the genotype.","tokens_in":9758,"feed_emoji":"🔬","tokens_out":4013,"duration_ms":44461,"temperature":0.7,"pith_summary":"This paper tries to establish that Brillouin microscopy can distinguish CRISPR-edited colon cancer cells from their wild-type counterparts by measuring their mechanical properties without any label. The evidence is a set of two cell populations imaged with a custom confocal Brillouin microspectrometer: twenty cells from each group gave median Brillouin shifts of 7.591 GHz (wild-type) versus 7.567 GHz (CRISPR) and median linewidths of 0.987 GHz versus 0.861 GHz. The paper reads the shift as a proxy for stiffness and the linewidth as a proxy for viscosity, so the CRISPR cells appear slightly less stiff and less viscous. A reader should care because a label-free optical readout of genetic state could feed into non-invasive cancer diagnostics and mechanobiology studies.","feed_headline":"Laser probe tells CRISPR-edited colon cancer cells apart","feed_subtitle":"Wild-type cells showed higher Brillouin shift and linewidth, a label-free mechanical fingerprint of the edit.","key_machinery":"The central readout is the Brillouin shift, the frequency change of light inelastically scattered by acoustic phonons, together with the full width at half maximum (FWHM) of the Brillouin peak. In the paper's setup, the shift is treated as a proxy for longitudinal stiffness and the FWHM as a proxy for viscous damping, so the two numbers together describe a cell's viscoelastic signature. The machinery that carries the claim is a custom-built confocal Brillouin microspectrometer with a VIPA spectrometer, iodine-cell rejection of elastic scattering, and a Savitzky-Golay spectral preprocessing step that converts CCD positions into calibrated frequency shifts and linewidths.","core_discovery":"The central claim is that Brillouin spectroscopy resolves a subtle but consistent mechanical difference between wild-type and CRISPR-modified colon cancer cells in vitro. In the paper's own numbers, the wild-type population had a higher median Brillouin shift (7.591 GHz) and a broader Brillouin peak (FWHM 0.987 GHz) than the CRISPR population (7.567 GHz and 0.861 GHz). The conclusion states that Brillouin spectroscopy can effectively resolve subtle differences in viscoelastic properties, and interprets the decrease in both parameters as a measurable alteration of cellular stiffness and viscosity linked to the genetic modification.","pith_inferences":["Editorial inference: the 0.024 GHz median shift difference is close to the system's frequency precision, so the paper's conclusion leans heavily on the FWHM difference, which is larger in relative terms.","Editorial inference: because the two samples differ in passage number, culture date, and medium label, a replication with passage-matched isogenic clones would be needed to attribute the mechanical change to the CRISPR edit itself.","Editorial inference: combining Brillouin maps with Raman spectra at the same pixels could test whether the mechanical change tracks a specific biochemical change, such as altered lipid or protein content.","Editorial inference: if the mechanical signature proves robust, it could be used to monitor organoid or patient-derived colon cancer models after gene editing without disrupting the culture."],"forward_implications":["If the difference is real, Brillouin microscopy can serve as a label-free phenotypic assay for CRISPR-induced changes in cancer cell mechanics.","The same readout could be used to screen edited cell populations for mechanical side effects before functional studies.","Because the measurement is non-invasive and works in culture flasks, it can be applied to living cells over time without fixation.","Lower Brillouin shift and FWHM in the edited cells suggest CRISPR modification altered both elastic and viscous components, not just stiffness.","The approach extends the prior use of Brillouin spectroscopy on tumor tissue to intact cultured cells at subcellular resolution."],"supporting_citations":[{"why":"Supplies the foundational account of Brillouin light scattering as a probe of biomedical viscoelasticity.","marker":"[28]"},{"why":"Prior demonstration that Brillouin microspectroscopy separates melanoma from healthy tissue by elasticity, which the present work extends to colon cancer cells.","marker":"[40]"},{"why":"Shows Brillouin microspectroscopy imaging of cancer cell mechanical properties during metastasis, establishing the cell-level imaging precedent.","marker":"[42]"},{"why":"Combines Brillouin and Raman spectroscopy on glioblastoma cells, motivating the use of Brillouin readouts for cancer cell phenotypes.","marker":"[46]"},{"why":"Applies coherent spectroscopy to human colorectal adenocarcinoma cells (HT-29), the direct colon-cancer precedent for Brillouin-based differentiation.","marker":"[48]"}],"fun_headline_variants":["Brillouin microscopy flags CRISPR edits in colon cancer cells","Label-free laser test tells CRISPR-modified cells apart","CRISPR alters colon cancer cell stiffness, Brillouin shows","Non-invasive Brillouin probe detects CRISPR changes in cancer cells","Mechanical fingerprint distinguishes wild-type and CRISPR colon cells"],"cache_read_input_tokens":3200,"weakest_assumption_plain":"The two cell populations are assumed to differ only by the intended CRISPR edit, yet the samples were identified by handwritten flask labels alone, with no genotyping to confirm the edit or rule out passage, media, or batch differences.","fun_headline_variants_meta":{"raw":{"variants":["Brillouin microscopy flags CRISPR edits in colon cancer cells","Label-free laser test tells CRISPR-modified cells apart","CRISPR alters colon cancer cell stiffness, Brillouin shows","Non-invasive Brillouin probe detects CRISPR changes in cancer cells","Mechanical fingerprint distinguishes wild-type and CRISPR colon cells"]},"model":"deepseek-v4-flash","effort":"low","cost_usd":0.000244,"raw_usage":{"total_tokens":1463,"prompt_tokens":809,"completion_tokens":654,"prompt_tokens_details":{"cached_tokens":384},"prompt_cache_hit_tokens":384,"prompt_cache_miss_tokens":425,"completion_tokens_details":{"reasoning_tokens":576}},"tokens_in":425,"tokens_out":654,"duration_ms":7124,"temperature":1.0,"reasoning_tokens":576,"cache_read_input_tokens":384,"cache_creation_input_tokens":0},"cache_creation_input_tokens":0},"created_at":"2026-08-06T19:28:47.994318+00:00","model_set":{"reader":"deepseek-v4-flash"},"falsifier":"A direct falsifier would be PCR or sequencing of the flask populations showing that the intended CRISPR modification is absent or present in only a minority of cells, or a blinded replication in which passage- and media-matched wild-type and edited clones produce overlapping medians for shift and FWHM. Another concrete check is to swap the sample identities between flasks and see whether the assignment follows the physical flask rather than the genotype.","supporting_citations":[{"cited_title":"Palombo and D","cited_arxiv_id":null,"evidence_quote":"Supplies the foundational account of Brillouin light scattering as a probe of biomedical viscoelasticity."},{"cited_title":"Troyanova-Wood, Zhaokai Meng, and V","cited_arxiv_id":null,"evidence_quote":"Prior demonstration that Brillouin microspectroscopy separates melanoma from healthy tissue by elasticity, which the present work extends to colon cancer cells."},{"cited_title":null,"cited_arxiv_id":null,"evidence_quote":"Shows Brillouin microspectroscopy imaging of cancer cell mechanical properties during metastasis, establishing the cell-level imaging precedent."},{"cited_title":"Rix, Ortrud Uckermann, K","cited_arxiv_id":null,"evidence_quote":"Combines Brillouin and Raman spectroscopy on glioblastoma cells, motivating the use of Brillouin readouts for cancer cell phenotypes."},{"cited_title":"Moguilnaya, A","cited_arxiv_id":null,"evidence_quote":"Applies coherent spectroscopy to human colorectal adenocarcinoma cells (HT-29), the direct colon-cancer precedent for Brillouin-based differentiation."}],"review_version":1}